How would you compound a Nystatin oral suspension at 10,000 units/mL combined with a dexamethasone mouthwash for an adult patient without known hypersensitivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Compounding Nystatin-Dexamethasone Mouthwash

To compound a nystatin 10,000 units/mL with dexamethasone mouthwash, dilute commercially available nystatin oral suspension (100,000 units/mL) 1:10 with dexamethasone 0.5 mg/5 mL oral solution to achieve the target nystatin concentration while incorporating the steroid component.

Practical Compounding Instructions

Starting Materials

  • Nystatin oral suspension: 100,000 units/mL (commercially available) 11
  • Dexamethasone oral solution: 0.5 mg/5 mL (alcohol-free preferred)

Compounding Formula

For a 100 mL final volume:

  • Take 10 mL of nystatin suspension (100,000 units/mL)
  • Add 90 mL of dexamethasone oral solution (0.5 mg/5 mL)
  • Mix thoroughly

This yields:

  • Nystatin concentration: 10,000 units/mL
  • Dexamethasone concentration: approximately 0.045 mg/mL

Stability Considerations

Store the compounded preparation at 5°C (refrigerated) and use within 7 days 2. Research demonstrates that nystatin at lower concentrations (14,400 units/mL) in alkaline environments maintains >90% potency for 7 days when refrigerated, but only 4 days at room temperature 2. Your 10,000 units/mL concentration should follow similar stability parameters.

Clinical Context

This combination addresses two therapeutic goals:

  1. Antifungal activity: Nystatin 10,000 units/mL provides adequate antifungal coverage for mild oropharyngeal candidiasis. Standard dosing for oral candidiasis uses nystatin suspension 100,000 units/mL at 4-6 mL four times daily 33, so your diluted preparation would require proportionally larger volumes (40-60 mL four times daily) to achieve equivalent total daily dosing.

  2. Anti-inflammatory prophylaxis: Dexamethasone mouthwash has proven efficacy in preventing drug-induced stomatitis, particularly with mTOR inhibitors, reducing grade ≥2 stomatitis from 33% to 2% 4. The steroid component reduces mucosal inflammation and may enhance patient tolerance.

Dosing Instructions

Instruct patients to swish 10 mL of the compounded solution for 1-2 minutes, then expectorate (spit out), four times daily 45. This swish-and-spit technique maximizes mucosal contact while minimizing systemic absorption of both agents.

Important Caveats

  • Do not swallow: Unlike standard nystatin suspension used for esophageal candidiasis, this steroid-containing mouthwash should be expectorated to avoid unnecessary systemic steroid exposure
  • Shake well before each use: Nystatin suspensions require agitation for uniform distribution 11
  • Use tinted glass bottles: Protects nystatin from light degradation 2
  • Refrigerate consistently: Temperature fluctuations accelerate nystatin degradation

Alternative Consideration

If compounding resources are limited, you could use the commercially available nystatin 100,000 units/mL suspension separately from dexamethasone mouthwash, having the patient swish with dexamethasone first, then follow with a smaller volume (1 mL) of full-strength nystatin. However, the combined preparation improves compliance by reducing the number of daily rinses from 8 to 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.